Drug Insight: abatacept for the treatment of rheumatoid arthritis-Reference-Cited by-同舟云学术

Drug Insight: abatacept for the treatment of rheumatoid arthritis

Published:2006-12 Issue:12 Volume:2 Page:654-660
ISSN:1745-8382
Container-title:Nature Clinical Practice Rheumatology
language:en
Short-container-title:Nat Rev Rheumatol

Author:

Ruderman Eric M,Pope Richard M

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://www.nature.com/articles/ncprheum0345.pdf

Reference25 articles.

1. Pope RM and Perlman H (1999) Rheumatoid arthritis: molecular pathogenesis. In Molecular Rheumatology, 325–361 (Ed. Dolgert P) New Jersey: Humana Press

2. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356–361

3. Keystone EC (2003) Abandoned therapies and unpublished trials in rheumatoid arthritis. Curr Opin Rheumatol 15: 253–258

4. Moreland LW et al. (2002) Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum 46: 1470–1479

5. Kremer JM et al. (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349: 1907–1915

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide;Frontiers in Immunology;2023-09-25

2. Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation;JCI Insight;2022-12-22

3. Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review;International Ophthalmology;2021-11-21

4. Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial;Contemporary Clinical Trials Communications;2020-09

5. Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis;Biomolecules;2020-08-19